CD40 and CD70 co-stimulate a potent in vivo antitumor T cell response.

Nieland, J D; Graus, Y F; Dortmans, Y E; Kremers, B L; Kruisbeek, A M

Nieland, J D; Graus, Y F; Dortmans, Y E; Kremers, B L; Kruisbeek, A M.

Affiliation

Nieland JD; Division of Immunology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Huis, Amsterdam.

J Immunother ; 21(3): 225-36, 1998 May.

Article in En | MEDLINE | ID: mdl-9610915

Subject(s)

Antigens, CD; CD40 Antigens/immunology; Membrane Proteins/immunology; Neoplasms, Experimental/immunology; T-Lymphocytes/immunology; Animals; Antibodies, Monoclonal; Antigens, Neoplasm/immunology; CD27 Ligand; CD4-Positive T-Lymphocytes/immunology; CD40 Antigens/genetics; CD8-Positive T-Lymphocytes/immunology; Genetic Therapy; Humans; Membrane Proteins/genetics; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Transplantation; Phenotype; T-Lymphocytes, Cytotoxic/immunology; Transfection; Tumor Cells, Cultured

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: T-Lymphocytes / Antigens, CD / CD40 Antigens / Membrane Proteins / Neoplasms, Experimental Limits: Animals / Humans Language: En Journal: J Immunother Journal subject: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Year: 1998 Document type: Article Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links